Eugenio Cardenal Virgil
Associate Director Regulatory Affiars CMC Johnson & Johnson
More than 20 years of regulatory experience, primarily in CMC, with a focus on product development and new MAA/BLA submissions. My background spans generics (small molecule) and innovative (small- and large-molecule) companies and now includes ADCs.
Seminars
Monday 8th March 2027
ADC Regulatory CMC 101: Introducing Core Principles, Guidance & Challenges Facing ADC Drug CMC & Submissions
- What differentiate ADCs from standard SM & LM
- What regulations apply specifically
- Introduction to key ADC concepts for CMC RA
